Subscribe to RSS
Download PDF
DOI: 10.1055/a-1908-0801
Nephropathie bei Diabetes
Authors
Die DDG-Praxisempfehlungen werden regelmäßig zur zweiten Jahreshälfte aktualisiert. Bitte stellen Sie sicher, dass Sie jeweils die neueste Version lesen und zitieren.
Empfehlung 1: Ergänzung der Allgemeinmaßnahmen
Begründung: Wichtige Maßnahmen zum Selbstmanagement der CKD
Stützende Quellenangabe: [11]
Empfehlung 2: Blutdruck-Zielwert gesenkt
Begründung: Aktuelle Leitlinienempfehlung
Stützende Quellenangabe: [12]
Empfehlung 3: Einsatz von nichtsteroidalen Mineralokortikoid-Rezeptorantagonisten in Zukunft
Begründung: Neue Daten aus Endpunktstudien
Stützende Quellenangabe: [13] [14]
Empfehlung 4: Einsatz von einigen SGLT-2-Inhibitoren auch im Stadium G4
Begründung: Neuere Daten
Stützende Quellenangabe: [11]
Publication History
Article published online:
18 October 2022
© 2022. Thieme. All rights reserved.
Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany
-
Literatur
- 1 Mogensen CE. Introduction: Diabetes mellitus and the kidney. Kidney Int 1982; 21: 673-675
- 2 KDIGO. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl 2013; 3: 1-150
- 3 Williams B, Mancia G, Spiering W. et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 2018; 39: 3021-3104
- 4 Buse JB, Wexler DJ, Tsapas A. et al. 2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 2020; 63: 221-228
- 5 Landgraf R, Aberle J, Birkenfeld AL. et al. Therapie des Typ-2-Diabetes. Diabetologie 2019; 14 (Suppl. 02) 167-187
- 6 Mach F, Baigent C, Catapano AL. et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J 2020; 41: 111-188
- 7
Kristensen SL,
Rørth R,
Jhund PS.
et al. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists
in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular
outcome trials. Lancet Diabetes Endocrinol 2019; 7: 776-785
Reference Ris Wihthout Link
- 8 Zelniker TA, Wiviott SD, Raz I. et al. SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet 2019; 393: 31-39
- 9
Perkovic V,
Jardine MJ,
Neal B.
et al. Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy. N Engl
J Med 2019; 380: 2295-2306
Reference Ris Wihthout Link
- 10
Heerspink HJL,
Stefánsson BV,
Correa-Rotter R.
et al
Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med 2020; 383: 1436-1446
Reference Ris Wihthout Link
- 11 Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease. Kidney Int 2020; 98 (Suppl. 04) 1-115
- 12 Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group. KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease. Kidney Int 2021; 99: 1-87
- 13 Bakris GL, Agarwal R, Anker SD. et al. Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. N Engl J Med 2020; 383: 2219-2229
- 14 Pitt B, Filippatos G, Agarwal R. et al Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes. N Engl J Med 2021; 385: 2252-2263
- 15 Bally L, Gubler P, Thabit H. et al Fully closed-loop insulin delivery improves glucose control of inpatients with type 2 diabetes receiving hemodialysis. Kidney Int 2019; 96: 593-596
- 16 Boughton CK. et al Fully automated closed-loop glucose control compared with standard insulin therapy in adults with type 2 diabetes requiring dialysis: an open-label, randomized crossover trial. Nat Med 2021; 27: 1471-1476 . Erratum in: Nat Med 2021; 27: 1850.